Osteoarthritis subpopulations and implications for clinical trial design

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Bierma Zeinstra, Sita M A ^a   Verhagen, Arianne P ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AVANS UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

BIOMECHANICS; CHONDROCALCINOSIS; COMORBIDITY; GENOTYPE; HUMAN; JOINT INJURY; OSTEOARTHRITIS; PAIN; PHENOTYPE; REVIEW; CLINICAL TRIAL (TOPIC); GENETICS; METHODOLOGY; PATHOLOGY; STANDARD;

CLINICAL TRIALS AS TOPIC; HUMANS; OSTEOARTHRITIS; RESEARCH DESIGN;

EID: 82155163808     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3299     Document Type: Review

References (81)

1. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162. 10.1016/j.joca.2007.12.013, 18279766.
2. Hunter DJ, Hellio L, Graverand-Gastineau MP. How close are we to having structure-modifying drugs available?. Med Clin North Am 2009, 93:223-234. 10.1016/j.mcna.2008.07.011, 19059031.
3. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, . EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005, 64:669-681. 10.1136/ard.2004.028886, 1755499, 15471891, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
4. National Collaborating Centre for Chronic Conditions Osteoarthritis: national clinical guideline for care and management in adults. 2008, London: Royal College of Physicians (UK), National Collaborating Centre for Chronic Conditions.
5. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005, 365:82-93. 10.1016/S0140-6736(04)17670-8, 15639683.
6. Hancock M, Herbert RD, Maher CG. A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions. Phys Ther 2009, 89:698-704. 10.2522/ptj.20080351, 19465372.
7. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001, 5:1-56.
8. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 2004, 57:229-236. 10.1016/j.jclinepi.2003.08.009, 15066682.
9. Sharp SJ, Thompson SG. Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med 2000, 19:3251-3274. 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2, 11113958.
10. Groenwold RH, Donders AR, van der Heijden GJ, Hoes AW, Rovers MM. Confounding of subgroup analyses in randomized data. Arch Intern Med 2009, 169:1532-1534. 10.1001/archinternmed.2009.250, 19752412.
11. Brandt KD, Dieppe P, Radin E. Etiopathogenesis of osteoarthritis. Med Clin North Am 2009, 93:1-24. 10.1016/j.mcna.2008.08.009, 19059018.
12. Felson DT. Identifying different osteoarthritis phenotypes through epidemiology. Osteoarthritis Cartilage 2010, 18:601-604. 10.1016/j.joca.2010.01.007, 20175975.
13. Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, Bierma-Zeinstra SM. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007, 66:158-162. 10.1136/ard.2006.053538, 1798486, 16837490.
14. Dahaghin S, Bierma-Zeinstra SM, Reijman M, Pols HA, Hazes JM, Koes BW. Does hand osteoarthritis predict future hip or knee osteoarthritis?. Arthritis Rheum 2005, 52:3520-3527. 10.1002/art.21375, 16255023.
15. Kalichman L, Guermazi A, Li L, Hunter DJ. Association between age, sex, BMI and CT-evaluated spinal degeneration features. J Back Musculoskelet Rehabil 2009, 22:189-195.
16. Evangelou E, Chapman K, Meulenbelt I, Karassa FB, Loughlin J, Carr A, Doherty M, Doherty S, Gómez-Reino JJ, Gonzalez A, Halldorsson BV, Hauksson VB, Hofman A, Hart DJ, Ikegawa S, Ingvarsson T, Jiang Q, Jonsdottir I, Jonsson H, Kerkhof HJ, Kloppenburg M, Lane NE, Li J, Lories RJ, van Meurs JB, Näkki A, Nevitt MC, Rodriguez-Lopez J, Shi D, Slagboom PE, et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 2009, 60:1710-1721. 10.1002/art.24524, 19479880.
17. Jónsson H, Valtýsdóttir ST, Kjartansson O, Brekkan A. Hypermobility associated with osteoarthritis of the thumb base: a clinical and radiological subset of hand osteoarthritis. Ann Rheum Dis 1996, 55:540-543. 1010234, 8774182.
18. Irlenbusch U, Schäller T. Investigations in generalized osteoarthritis. Part 1: genetic study of Heberden's nodes. Osteoarthritis Cartilage 2006, 14:423-427. 10.1016/j.joca.2005.11.016, 16443379.
19. Duncan R, Peat G, Thomas E, Wood L, Hay E, Croft P. Does isolated patellofemoral osteoarthritis matter?. Osteoarthritis Cartilage 2009, 17:1151-1155. 10.1016/j.joca.2009.03.016, 19401244.
20. Hunter DJ, March L, Sambrook PN. The association of cartilage volume with knee pain. Osteoarthritis Cartilage 2003, 11:725-729. 10.1016/S1063-4584(03)00160-2, 13129691.
21. Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ, Garnero P, Hellio-Le Graverand MP, DeGroot J, Slagboom PE. Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthritis Cartilage 2007, 15:379-385. 10.1016/j.joca.2006.09.007, 17052923.
22. De Graaf IC, Prak A, Bierma-Zeinstra SMA, Thomas S, Peul WC, Koes BW. Diagnosis of lumbar spinal stenosis: a systematic review of the accuracy of diagnostic tests. Spine 2006, 31:1168-1176. 10.1097/01.brs.0000216463.32136.7b, 16648755.
23. Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R. Understanding the pain experience in hip and knee osteoarthritis - an OARSI/OMERACT initiative. Osteoarthritis Cartilage 2008, 16:415-422. 10.1016/j.joca.2007.12.017, 18296075.
24. Svensson O, Malmenäs M, Fajutrao L, Roos EM, Lohmander LS. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36. Ann Rheum Dis 2006, 65:781-784. 10.1136/ard.2005.040519, 1798184, 16269428.
25. Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) 2007, 46:496-507. 10.1093/rheumatology/kel296, 16936327.
26. Detora LM, Krupa D, Bolognese J, Sperling RS, Ehrich EW. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors. J Rheumatol 2001, 28:2494-2503.
27. Hernández-Molina G, Reichenbach S, Zhang B, Lavalley M, Felson DT. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis. Arthritis Rheum 2008, 59:1221-1228. 2758534, 18759315.
28. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S, Fujioka M, Sudo A, Uchida A, Yamamoto S, Ozaki K, Takigawa M, Tanaka T, Nakamura Y, Jiang Q, Ikegawa S. A functional polymorphism in the 5'UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007, 39:529-533. 10.1038/2005, 17384641.
29. MacGregor A, Li Q, Spector TD, Williams FMK. The genetic influence on radiographic osteoarthritis is site specific at the hand, hip and knee. Rheumatology (Oxford) 2009, 48:277-280. 10.1093/rheumatology/ken475, 2644047, 19153142.
30. Min JL, Meulenbelt I, Kloppenburg M, van Duijn CM, Slagboom PE. Mutation analysis of candidate genes within the 2q33.3 linkage area for familial early-onset generalised osteoarthritis. Eur J Hum Genet 2007, 15:791-799. 10.1038/sj.ejhg.5201829, 17406639.
31. Belo JN, Berger MY, Reijman M, Koes BW, Bierma-Zeinstra SMA. Prognostic factors of progression of osteoarthritis of the knee - a systematic review of observational studies. Arthritis Rheum 2007, 57:13-26. 10.1002/art.22475, 17266080.
32. Dougados M, Nakache JP, Gueguen A. Criteria for generalized and focal osteoarthritis. Rev Rhum Engl Ed 1996, 63:569-575.
33. Rozendaal RM, Uitterlinden EJ, van Osch GJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Koes BW, Bierma-Zeinstra SM. Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial. Osteoarthritis Cartilage 2009, 17:427-432. 10.1016/j.joca.2008.05.022, 18848470.
34. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, Verhaar JA, Koes BW. Prognostic factors of progress of hip osteoarthritis: a systematic review. Arthritis Rheum 2002, 47:556-562. 10.1002/art.10660, 12382307.
35. Conrozier T, Ferrand F, Poole AR, Verret C, Mathieu P, Ionescu M, Vincent F, Piperno M, Spiegel A, Vignon E. Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies. Osteoarthritis Cartilage 2007, 15:462-467. 10.1016/j.joca.2006.09.002, 17055306.
36. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Kaklamanis P, Kloppenburg M, Lohmander LS, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Smolen J, Verbruggen G, Watt I, Zimmermann-Gorska I, . ESCISIT EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 2009, 68:8-17. 10.1136/ard.2007.084772, 18250111, ESCISIT.
37. Punzi L, Frigato M, Frallonardo P, Ramonda R. Inflammatory osteoarthritis of the hand. Best Pract Res Clin Rheumatol 2010, 24:301-312. 10.1016/j.berh.2009.12.007, 20534365.
38. Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis-role of ANKH. Nat Rev Rheumatol 2011, 7:96-104. 10.1038/nrrheum.2010.182, 21102543.
39. Rosenthal AK. Calcium crystal deposition and osteoarthritis. Rheum Dis Clin North Am 2006, 32:401-412. 10.1016/j.rdc.2006.02.004, 16716886.
40. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Pascual E. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011, 70:563-570. 10.1136/ard.2010.139105, 21216817.
41. Neogi T, Nevitt M, Niu J, LaValley MP, Hunter DJ, Terkeltaub R, Carbone L, Chen H, Harris T, Kwoh K, Guermazi A, Felson DT. Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum 2006, 54:1822-1828. 10.1002/art.21903, 16729275.
42. Sharma L, Song J, Dunlop D, Felson D, Lewis CE, Segal N, Torner J, Cooke TD, Hietpas J, Lynch J, Nevitt M. Varus and valgus alignment and incident and progressive knee osteoarthritis. Ann Rheum Dis 2010, 69:1940-1945.
43. Brouwer GM, van Tol AW, Bergink AP, Belo JN, Bernsen RM, Reijman M, Pols HA, Bierma-Zeinstra SM. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum 2007, 56:1204-1211. 10.1002/art.22515, 17393449.
44. Carney BT, Weinstein SL, Noble J. Long-term follow-up of slipped capital femoral epiphysis. J Bone Joint Surg Am 1991, 73:667-674.
45. Reijman M, Hazes JM, Pols HA, Koes BW, Bierma-Zeinstra SM. Acetabular dysplasia predicts incident osteoarthritis of the hip: the Rotterdam study. Arthritis Rheum 2005, 52:787-793. 10.1002/art.20886, 15751071.
46. Englund M. The role of biomechanics in the initiation and progression of OA of the knee. Best Pract Res Clin Rheumatol 2010, 24:39-46. 10.1016/j.berh.2009.08.008, 20129198.
47. Catterall JB, Stabler TV, Flannery CR, Kraus VB. Changes in serum and synovial fluid biomarkers after acute injury. Arthritis Res Ther 2010, 12:R229. 10.1186/ar3216, 3046542, 21194441.
48. Lim BW, Hinman RS, Wrigley TV, Sharma L, Bennell KL. Does knee malalignment mediate the effects of quadriceps strengthening on knee adduction moment, pain, and function in medial knee osteoarthritis? A randomized controlled trial. Arthritis Rheum 2008, 59:943-951. 10.1002/art.23823, 18576289.
49. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009, 11:203. 10.1186/ar2531, 2688214, 19232065.
50. Hernández-Molina G, Neogi T, Hunter DJ, Niu J, Guermazi A, Roemer FW, McLennan CE, Reichenbach S, Felson DT. The association of bone attrition with knee pain and other MRI features of osteoarthritis. Ann Rheum Dis 2008, 67:43-47.
51. Suri S, Gill SE, Massena de Camin S, Wilson D, McWilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis 2007, 66:1423-1428. 10.1136/ard.2006.063354, 2111605, 17446239.
52. Hill CL, Gale DR, Chaisson CE, Skinner K, Kazis L, Gale ME, Felson DT. Periarticular lesions detected on magnetic resonance imaging: prevalence in knees with and without symptoms. Arthritis Rheum 2003, 48:2836-2844. 10.1002/art.11254, 14558089.
53. Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen HU, Jensen TS. Using screening tools to identify neuropathic pain. Pain 2007, 127:199-203. 10.1016/j.pain.2006.10.034, 17182186.
54. Nijs J, Van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Man Ther 2010, 15:135-141. 10.1016/j.math.2009.12.001, 20036180.
55. Valdes AM, Spector TD. The clinical relevance of genetic susceptibility to osteoarthritis. Best Pract Res Clin Rheumatol 2010, 24:3-14. 10.1016/j.berh.2009.08.005, 20129195.
56. van Meurs JB, Uitterlinden AG, Stolk L, Kerkhof HJ, Hofman A, Pols HA, Bierma-Zeinstra SM. A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum 2009, 60:628-629. 10.1002/art.24175, 19180497.
57. Nackley AG, Diatchenko L. Assessing potential functionality of catechol-O-methyltransferase (COMT) polymorphisms associated with pain sensitivity and temporomandibular joint disorders. Methods Mol Biol 2010, 617:375-393. full_text, 20336436.
58. Stamer UM, Zhang L, Stüber F. Personalized therapy in pain management: where do we stand?. Pharmacogenomics 2010, 11:843-864. 10.2217/pgs.10.47, 20504256.
59. Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritis knees: correlation between MR imaging and histologic findings. Radiology 2000, 215:835-840.
60. Goldring SR. Role of bone in osteoarthritis pathogenisis. Med Clin North Am 2009, 93:25-35. 10.1016/j.mcna.2008.09.006, 19059019.
61. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, Luta G, Callahan LF, Wang X, Schwartz T, Abramson SB, Caldwell JR, Harrell RA, Kremer JM, Lautzenheiser RL, Markenson JA, Schnitzer TJ, Weaver A, Cummins P, Wilson A, Morant S, Fort J. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001, 44:1587-1598. 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X, 11465710.
62. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: Factors influencing the clinical response. Annals Rheum Dis 1995, 54:379-381.
63. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Annals Rheum Dis 1996, 55:829-832.
64. Chao J, Wu C, Sun B, Hose MK, Quan A, Hughes TH, Boyle D, Kalunian KC. Inflammatory characteristics on ultrasound predict poorer long-term response to intra-articular corticosteroid injections in knee osteoarthritis. J Rheumatol 2010, 37:650-655. 10.3899/jrheum.090575, 20080918.
65. Reeuwijk KG, de Rooij M, van Dijk GM, Veenhof C, Steultjens MP, Dekker J. Osteoarthritis of the hip or knee: which coexisting disorders are disabling?. Clin Rheumatol 2010, 29:739-747. 10.1007/s10067-010-1392-8, 2878451, 20177725.
66. Tannenbaum H, Bombardier C, Davis P, Russel AS, . Third Canadian Consensus Conference Group An evidence based approach to prescribing nonsteroidal anti-inflammatory drugs. J Rheumatol 2006, 33:140-157. Third Canadian Consensus Conference Group.
67. Suri P, Morgenroth DC, Kwoh CK, Bean JF, Kalichman L, Hunter DJ. Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken) 2010, 62:1715-1723. 10.1002/acr.20324, 20799265.
68. Wesseling J, Bierma-Zeinstra SM, Dekker J, Gorter KJ, Roorda LD, Bijlsma JW. Self reported comorbidity and health status in early OA: The CHECK study. Osteoarthritis Cartilage 2010, 18 Suppl 2:S127-S128.
69. Stupar M, Côté P, French MR, Hawker GA. The association between low back pain and osteoarthritis of the hip and knee: a population-based cohort study. J Manipulative Physiol Ther 2010, 33:349-354. 10.1016/j.jmpt.2010.05.008, 20605553.
70. Parvizi J, Pour AE, Hillibrand A, Goldberg G, Sharkey PF, Rothman RH. Back pain and total hip arthroplasty: a prospective natural history study. Clin Orthop Relat Res 2010, 468:1325-1330. 10.1007/s11999-010-1236-5, 20127429.
71. Sale JE, Gignac M, Hawker G. The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis. J Rheumatol 2008, 35:335-342.
72. Runhaar J, Koes B, Bierma-Zeinstra S. Obesity and biomechanics of everyday movements; a systematic review. Osteoarthritis Cartilage 2009, 17 Suppl 1:S91.
73. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007, 14:1095-1100. 10.2174/092986707780362826, 17456023.
74. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA, De Clerck LS, Somville J. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010, 18:876-882. 10.1016/j.joca.2010.03.014, 20417297.
75. de Klerk BM, Schiphof D, Koes BW, Bierma-Zeinstra SM. Risk factors and symptomatic symtoms of radiological knee osteoarthritis: Does BMI make a difference?. Osteoarthritis Cartilage 2010, 18 Suppl 2:S152-S152.
76. de Klerk BM, Schiphof D, Groeneveld FPMJ, Koes BW, van Osch GJVM, van Meurs JBJ, Bierma-Zeinstra SMA. No clear association between female-hormonal aspects and osteoarthritis of the hand, hip and knee: A systematic review. Rheumatology 2009, 48:1160-1165. 10.1093/rheumatology/kep194, 19608726.
77. de Klerk BM, Schiphof D, Groeneveld FPMJ, Koes BW, van Osch GJVM, van Meurs JBJ, Bierma-Zeinstra SMA. Limited evidence for a protective effect of unopposed oestrogen therapy for osteoarthritis of the hip. Rheumatology 2009, 48:104-112. 10.1093/rheumatology/ken390, 19000994.
78. Gast GC, Pop VJ, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, Wijnands-van Gent CJ, van der Schouw YT. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 2011, 18:146-151.
79. Keefe FJ, Smith SJ, Buffington AL, Gibson J, Studts JL, Caldwell DS. Recent advances and future directions in the biopsychosocial assessment and treatment of arthritis. J Consult Clin Psychol 2002, 70:640-655. 10.1037/0022-006X.70.3.640, 12090374.
80. Preference Collaboration Review Group Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008, 337:a1864. 10.1136/bmj.a1864, 2659956, 18977792, Preference Collaboration Review Group.
81. Veenhof C, Van den Ende CH, Dekker J, Kiike AJ, Oostendorp RA, Bijlsma JW. Which patients with osteoarthritis of hip and/or knee benefit most from behavioral graded activity?. Int J Behav Med 2007, 14:86-91. 10.1007/BF03004173, 17926436.